Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 3Urinary Bladder Neoplasms 2Sarcoma 2Prostatic Neoplasms 2Pancreatic Cyst 2Neoplasms 2Melanoma 2Stomach Neoplasms 1Stage IB Cervical Cancer FIGO 2018 1Spondylitis, Ankylosing 1Psoriasis 1Papillomavirus Infections 1Pancreatic Neoplasms 1Pancreatic Diseases 1Ovarian Neoplasms 1Neoplasm Metastasis 1Lupus Erythematosus, Systemic 1Kidney Neoplasms 1Inflammatory Bowel Diseases 1Hepatitis B, Chronic 1Giant Cell Tumor of Bone 1Crohn Disease 1Colitis, Ulcerative 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Bone Neoplasms 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Arthritis, Reactive 1

Interventions

anifrolumab 1Standard of Care 1Procalcitonin 1Practice Guidelines as Topic 1Methods 1Interviews as Topic 1Immune Checkpoint Inhibitors 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Lupus Erythematosus, Systemic × Methods × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡